Blog Posts by Deepak Shenoy

  • China iPhone sales boost Apple; shares up modestly

    REUTERS - Apple Inc (AAPL.O) beat Wall Street's revenue and profit forecasts on Monday as it sold more iPhones in China than the United States for the first time, but the company gave no sales figures for its new Apple Watch.

    Apple's iPhone sales in China soared, increasing its revenue in the country 71 percent to $16.8 billion, although that was helped by gift-buying for Chinese New Year.

    Chief Executive Tim Cook said that China's expanding middle class is fueling iPhone sales there, which is the bulk of the company's sales. The iPhone 6 was launched last autumn in China with a number of carriers.

    Wall Street hailed the results but share reaction was muted.

    Its shares rose 1.6 percent in after-hours trading to $134.52.

    Apple sold 61.2 million iPhones in the quarter, up 40 percent from the year-ago quarter, but down from the record-breaking holiday quarter. It sold 12.6 million iPads, down 23 percent from a

    Read More »from China iPhone sales boost Apple; shares up modestly
  • Kudelski Group and The Walt Disney Company Sign Patent License Agreement

    CHESEAUX-SUR-LAUSANNE, Switzerland--(BUSINESS WIRE)--

    The Kudelski Group (SIX:KUD.S), a leading independent provider of media protection and value-added service technology, today announced a multi-year patent license agreement with The Walt Disney Company, headquartered in Burbank, California. While the specific terms remain confidential, this agreement provides The Walt Disney Company with a license to the Kudelski Group’s patent portfolio, subject to certain limitations.

    "The Kudelski Group continues to invest heavily in developing technology and intellectual property that help enable industry leaders like The Walt Disney Company to deliver their popular, world-class video and entertainment platforms to the market through streaming video properties, such as ESPN.com and ABC.com,” said Joe Chernesky, Senior Vice President of Intellectual Property and Innovation at the Kudelski

    Read More »from Kudelski Group and The Walt Disney Company Sign Patent License Agreement
    Contact:
    Kudelski Group
    Phil Mundwiller, +41 21 732 01 81
    Head of Corporate Communications
    Phil.mundwiller@nagra.com
    or
    Santino Rumasuglia, +41 21 732 01 24
    Head of Investor Relations
    santino.rumasuglia@nagra.com
    or
    Carol Pohlod, +41 79 394 72 30
    Intellectual Property & Innovation
    carol.pohlod@nagra.com
  • Summations expected in Hamptons rape trial of NYC executive

    Summations expected to be held in trial of NYC executive accused of raping woman in Hamptons

    RIVERHEAD, N.Y. (AP) -- Closing arguments are expected to be held Tuesday in the trial of a New York City investment banker accused of raping an Irish tourist on Long Island.

    Former Goldman Sachs executive Jason Lee has pleaded not guilty to raping a 20-year-old woman in the bathroom of an East Hampton home he rented in the summer of 2013.

    Prosecutors say Lee met the woman at a nightclub in the Hamptons while celebrating his birthday. She and her friends went to Lee's home following a night of drinking.

    Lee is accused of sexually assaulting the woman in the bathroom while her friends were in the kitchen.

    The victim returned from Ireland to testify. The case is being closely followed by Irish media.

    Defense attorney Andrew Lankler argues the sex was consensual.

  • Europe seen lower; Fed meeting eyed

    European equities are expected to open in the negative territory Tuesday as caution sets in ahead of a meeting by the U.S. Federal Reserve policymakers.

    The FTSE (FTSE International: .FTSE) is seen opening lower by 28 points at 7,075, the German DAX (^GDAXI) down 43 points at 11,996 and the French CAC (Euronext Paris: .FCHI) down 30 points at 5,238.

    The Federal Open Market Committee begins a two-day meeting Tuesday, with an interest rates decision due on Wednesday. The announcement of the rates decision could offer more clues about when interest rates in the U.S. will be raised.

    In European news, Greek Prime Minister Alexis Tsipras said on Tuesday that he would have to resort to a popular referendum if lenders insist on demands that the government deems unacceptable but was confident of striking a deal to avoid such a scenario, Reuters reported.

    "If the solution falls outside our mandate, I will not have the right to violate it, so the solution to which we will come to will

    Read More »from Europe seen lower; Fed meeting eyed
  • Sopra Steria Group: Revenue for 1st quarter 2015: €872.0 million

    Organic growth: 2.4%

    PARIS--(BUSINESS WIRE)--

    Regulatory News:

    Sopra Steria Group (Paris:SOP) announces revenue of €872.0 million for the first quarter of 2015, representing organic growth of 2.4%.

    Revenue - 1st quarter 2015
    €m   Q1 2015  

    Q1 2014 Sopra reported

     

    Q1 2014 Pro forma

      Organic growth   Total growth
                       
    Read More »from Sopra Steria Group: Revenue for 1st quarter 2015: €872.0 million
    Contact:
    Investor Relations
    Sopra Steria
    Olivier Psaume, +33 (0)1 40 67 68 16
    olivier.psaume@soprasteria.com
    or
    Press Relations
    Image 7
    Caroline Simon, +33 (0)1 53 70 74 65
    caroline.simon@image7.fr
    or
    Simon Zaks, +33 (0)1 53 70 74 63
    szaks@image7.fr
  • Offerpop Expands Industry-Leading Engagement Marketing Platform with Consumer Data Product

    Unites engagement experiences, user-generated content management, consumer data, and analytics in the most complete engagement solution for consumer marketers

    LONDON--(BUSINESS WIRE)--

    Offerpop recently announced the addition of a consumer data product to its engagement marketing software-as-a-service platform, empowering brands to develop rich consumer profiles, perform advanced segmentation and analysis, and activate consumers through highly targeted and personalized marketing initiatives.

    Offerpop now provides a groundbreaking new way for brands to collect, own, and manage the valuable social, behavioral and affinity data acquired when consumers engage with them across channels – from mobile and social to email and e-commerce. Offerpop automatically aggregates and appends the data to dynamic individual consumer profiles owned by the brand and managed within the Offerpop platform, enriching these profiles over time as consumers continue to interact with brand experiences. This “top of funnel” engagement data can be unified with

    Read More »from Offerpop Expands Industry-Leading Engagement Marketing Platform with Consumer Data Product
    Contact:
    The Abbi Agency
    Constance Aguilar, 775-323-2977
    constance@theabbiagency.com

  • Bone Therapeutics Reports 2014 Financial and Operational Results

    Transformational Year Culminating in Successful € 37 million IPO on Euronext Brussels and Euronext Paris

    GOSSELIES, Belgium--(BUSINESS WIRE)--

    Regulatory News:

    BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), a leader in bone cell therapy addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, today announces the publication of its annual report including the consolidated full year results for 2014, prepared in accordance with IFRS as adopted by the European Union.

    Enrico Bastianelli, CEO of Bone Therapeutics, commented: “The past year has been one of significant transformation in the development of Bone Therapeutics, with the initiation of two new Phase II studies, the acceleration of our Phase III programs and the transition to a public company. We look forward to the next steps in bringing our innovative cell therapies closer to commercialization.”

    Operational Highlights

    • Progressed its two ongoing
    Read More »from Bone Therapeutics Reports 2014 Financial and Operational Results
    Contact:
    Bone Therapeutics SA
    Enrico Bastianelli, +32 (0)2 529 59 90
    Chief Executive Officer
    investorrelations@bonetherapeutics.com
    or
    Wim Goemaere, +32 (0)2 529 59 90
    Chief Financial Officer
    investorrelations@bonetherapeutics.com
    or
    For Belgium and International Media Enquiries
    Consilium Strategic Communications
    Amber Bielecka, Mary-Jane Elliott, Jessica Hodgson and Lindsey Neville
    +44 (0) 20 3709 5701
    bonetherapeutics@consilium-comms.com
    or
    For French Media and Investor Enquiries
    NewCap Investor Relations & Financial Communications
    Pierre Laurent and Antoine Denry
    + 33 (0)1 44 71 94 94
    bone@newcap.fr

  • GOSSELIES, Belgium--(BUSINESS WIRE)--

    Regulatory News:

    BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, informs its shareholders that the Annual General Meeting will be held on 28 May 2015 at 4pm at 37 Rue Auguste Piccard, 6041 Gosselies, Belgium.

    The notice for the meeting, including the agenda of the day as well as the motions too vote, have been published in the Belgian Official Gazette and L’Echo on 28 April 2015.

    The documents and preliminary information concerning this meeting are being made available to the shareholders and can be consulted on the website of the Company: www.bonetherapeutics.com, under the section Investors / Shareholders meeting, in compliance with the applicable law and regulations.

    It is

    Read More »from Bone Therapeutics: The Preparatory Documents for the Annual General Shareholder Meeting on 28 May 2015 Have Been Made Available
    Contact:
    Bone Therapeutics SA
    Enrico Bastianelli, Chief Executive Officer / Wim Goemaere, Chief Financial Officer
    Tel: +32 (0)2 529 59 90
    investorrelations@bonetherapeutics.com
    or
    For Belgium and International Media Enquiries
    Consilium Strategic Communications
    Amber Bielecka, Mary-Jane Elliott, Jessica Hodgson and Lindsey Neville
    Tel: +44 (0) 20 3709 5701
    bonetherapeutics@consilium-comms.com
    or
    For French Media and Investor Enquiries
    NewCap Investor Relations & Financial Communications
    Pierre Laurent and Antoine Denry
    Tel: + 33 (0)1 44 71 94 94
    bone@newcap.fr
  • CAMBRIDGE, Mass.--(BUSINESS WIRE)--

    Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has granted Fast Track designation for the development of GZ/SAR402671, a new investigational oral substrate reduction therapy for the treatment of Fabry disease.

    FDA’s Fast Track Drug Development Program is designed to facilitate frequent interactions with the FDA review team to expedite the clinical development and review of a New Drug Application (NDA) for medicines with the potential to treat serious or life-threatening conditions and address unmet medical needs for such disease or conditions. It also provides the opportunity to submit sections of an NDA on a rolling basis before a sponsor submits the complete application. Genzyme is currently enrolling patients in its Phase 2a trial of GZ/SAR402671, and plans to enroll nine treatment-naïve male adult

    Read More »from FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease
    Contact:
    Genzyme Media Relations
    Lori Gorski +1 617-768-9344
    lori.gorski@genzyme.com
    or
    Sanofi Investor Relations
    Sébastien Martel, +33 (0) 1 53 77 45 43
    ir@sanofi.com
  • LONDON--(BUSINESS WIRE)--

    DigitalGlobe, Inc. (DGI), a leading global provider of high-resolution earth imagery and geospatial solutions, today announced the general availability of its Basemap +Vivid product for the entire African continent. Keeping pace with the rapid evolution of mapping technology, this is the first time that a complete, consistent satellite imagery base layer with 50 cm ground resolution has been available for Africa.

    Many parts of Africa have never been mapped at this resolution from space, and never before has there been a complete imagery base map of Africa with this level of detail. While 50 cm satellite imagery for Africa has been available since 2008, it previously only covered smaller areas of interest. To meet the rapidly growing needs of our customers, DigitalGlobe purposed our satellite constellation to cover every country in Africa so we

    Read More »from DigitalGlobe Produces the World’s First Complete and Consistent High Resolution Satellite Imagery Base Map of Africa
    Contact:
    DigitalGlobe
    Nancy Coleman, 303-684-1674
    Senior Director of Communications
    nancy.coleman@digitalglobe.com
    or
    Investor Relations Contact:
    David Banks, 303-684-4210
    Vice President of Investor Relations
    ir@digitalglobe.com
    or
    Edelman for DigitalGlobe
    digitalglobe@edelman.com

Blog Posts by Deepak Shenoy

  • China iPhone sales boost Apple; shares up modestly

    REUTERS - Apple Inc (AAPL.O) beat Wall Street's revenue and profit forecasts on Monday as it sold more iPhones in China than the United States for the first time, but the company gave no sales figures for its new Apple Watch.

    Apple's iPhone sales in China soared, increasing its revenue in the country 71 percent to $16.8 billion, although that was helped by gift-buying for Chinese New Year.

    Chief Executive Tim Cook said that China's expanding middle class is fueling iPhone sales there, which is the bulk of the company's sales. The iPhone 6 was launched last autumn in China with a number of carriers.

    Wall Street hailed the results but share reaction was muted.

    Its shares rose 1.6 percent in after-hours trading to $134.52.

    Apple sold 61.2 million iPhones in the quarter, up 40 percent from the year-ago quarter, but down from the record-breaking holiday quarter. It sold 12.6 million iPads, down 23 percent from a

    Read More »from China iPhone sales boost Apple; shares up modestly
  • Kudelski Group and The Walt Disney Company Sign Patent License Agreement

    CHESEAUX-SUR-LAUSANNE, Switzerland--(BUSINESS WIRE)--

    The Kudelski Group (SIX:KUD.S), a leading independent provider of media protection and value-added service technology, today announced a multi-year patent license agreement with The Walt Disney Company, headquartered in Burbank, California. While the specific terms remain confidential, this agreement provides The Walt Disney Company with a license to the Kudelski Group’s patent portfolio, subject to certain limitations.

    "The Kudelski Group continues to invest heavily in developing technology and intellectual property that help enable industry leaders like The Walt Disney Company to deliver their popular, world-class video and entertainment platforms to the market through streaming video properties, such as ESPN.com and ABC.com,” said Joe Chernesky, Senior Vice President of Intellectual Property and Innovation at the Kudelski

    Read More »from Kudelski Group and The Walt Disney Company Sign Patent License Agreement
    Contact:
    Kudelski Group
    Phil Mundwiller, +41 21 732 01 81
    Head of Corporate Communications
    Phil.mundwiller@nagra.com
    or
    Santino Rumasuglia, +41 21 732 01 24
    Head of Investor Relations
    santino.rumasuglia@nagra.com
    or
    Carol Pohlod, +41 79 394 72 30
    Intellectual Property & Innovation
    carol.pohlod@nagra.com
  • Summations expected in Hamptons rape trial of NYC executive

    Summations expected to be held in trial of NYC executive accused of raping woman in Hamptons

    RIVERHEAD, N.Y. (AP) -- Closing arguments are expected to be held Tuesday in the trial of a New York City investment banker accused of raping an Irish tourist on Long Island.

    Former Goldman Sachs executive Jason Lee has pleaded not guilty to raping a 20-year-old woman in the bathroom of an East Hampton home he rented in the summer of 2013.

    Prosecutors say Lee met the woman at a nightclub in the Hamptons while celebrating his birthday. She and her friends went to Lee's home following a night of drinking.

    Lee is accused of sexually assaulting the woman in the bathroom while her friends were in the kitchen.

    The victim returned from Ireland to testify. The case is being closely followed by Irish media.

    Defense attorney Andrew Lankler argues the sex was consensual.

  • Europe seen lower; Fed meeting eyed

    European equities are expected to open in the negative territory Tuesday as caution sets in ahead of a meeting by the U.S. Federal Reserve policymakers.

    The FTSE (FTSE International: .FTSE) is seen opening lower by 28 points at 7,075, the German DAX (^GDAXI) down 43 points at 11,996 and the French CAC (Euronext Paris: .FCHI) down 30 points at 5,238.

    The Federal Open Market Committee begins a two-day meeting Tuesday, with an interest rates decision due on Wednesday. The announcement of the rates decision could offer more clues about when interest rates in the U.S. will be raised.

    In European news, Greek Prime Minister Alexis Tsipras said on Tuesday that he would have to resort to a popular referendum if lenders insist on demands that the government deems unacceptable but was confident of striking a deal to avoid such a scenario, Reuters reported.

    "If the solution falls outside our mandate, I will not have the right to violate it, so the solution to which we will come to will

    Read More »from Europe seen lower; Fed meeting eyed
  • Sopra Steria Group: Revenue for 1st quarter 2015: €872.0 million

    Organic growth: 2.4%

    PARIS--(BUSINESS WIRE)--

    Regulatory News:

    Sopra Steria Group (Paris:SOP) announces revenue of €872.0 million for the first quarter of 2015, representing organic growth of 2.4%.

    Revenue - 1st quarter 2015
    €m   Q1 2015  

    Q1 2014 Sopra reported

     

    Q1 2014 Pro forma

      Organic growth   Total growth
                       
    Read More »from Sopra Steria Group: Revenue for 1st quarter 2015: €872.0 million
    Contact:
    Investor Relations
    Sopra Steria
    Olivier Psaume, +33 (0)1 40 67 68 16
    olivier.psaume@soprasteria.com
    or
    Press Relations
    Image 7
    Caroline Simon, +33 (0)1 53 70 74 65
    caroline.simon@image7.fr
    or
    Simon Zaks, +33 (0)1 53 70 74 63
    szaks@image7.fr
  • Offerpop Expands Industry-Leading Engagement Marketing Platform with Consumer Data Product

    Unites engagement experiences, user-generated content management, consumer data, and analytics in the most complete engagement solution for consumer marketers

    LONDON--(BUSINESS WIRE)--

    Offerpop recently announced the addition of a consumer data product to its engagement marketing software-as-a-service platform, empowering brands to develop rich consumer profiles, perform advanced segmentation and analysis, and activate consumers through highly targeted and personalized marketing initiatives.

    Offerpop now provides a groundbreaking new way for brands to collect, own, and manage the valuable social, behavioral and affinity data acquired when consumers engage with them across channels – from mobile and social to email and e-commerce. Offerpop automatically aggregates and appends the data to dynamic individual consumer profiles owned by the brand and managed within the Offerpop platform, enriching these profiles over time as consumers continue to interact with brand experiences. This “top of funnel” engagement data can be unified with

    Read More »from Offerpop Expands Industry-Leading Engagement Marketing Platform with Consumer Data Product
    Contact:
    The Abbi Agency
    Constance Aguilar, 775-323-2977
    constance@theabbiagency.com

  • Bone Therapeutics Reports 2014 Financial and Operational Results

    Transformational Year Culminating in Successful € 37 million IPO on Euronext Brussels and Euronext Paris

    GOSSELIES, Belgium--(BUSINESS WIRE)--

    Regulatory News:

    BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), a leader in bone cell therapy addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, today announces the publication of its annual report including the consolidated full year results for 2014, prepared in accordance with IFRS as adopted by the European Union.

    Enrico Bastianelli, CEO of Bone Therapeutics, commented: “The past year has been one of significant transformation in the development of Bone Therapeutics, with the initiation of two new Phase II studies, the acceleration of our Phase III programs and the transition to a public company. We look forward to the next steps in bringing our innovative cell therapies closer to commercialization.”

    Operational Highlights

    • Progressed its two ongoing
    Read More »from Bone Therapeutics Reports 2014 Financial and Operational Results
    Contact:
    Bone Therapeutics SA
    Enrico Bastianelli, +32 (0)2 529 59 90
    Chief Executive Officer
    investorrelations@bonetherapeutics.com
    or
    Wim Goemaere, +32 (0)2 529 59 90
    Chief Financial Officer
    investorrelations@bonetherapeutics.com
    or
    For Belgium and International Media Enquiries
    Consilium Strategic Communications
    Amber Bielecka, Mary-Jane Elliott, Jessica Hodgson and Lindsey Neville
    +44 (0) 20 3709 5701
    bonetherapeutics@consilium-comms.com
    or
    For French Media and Investor Enquiries
    NewCap Investor Relations & Financial Communications
    Pierre Laurent and Antoine Denry
    + 33 (0)1 44 71 94 94
    bone@newcap.fr

  • GOSSELIES, Belgium--(BUSINESS WIRE)--

    Regulatory News:

    BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, informs its shareholders that the Annual General Meeting will be held on 28 May 2015 at 4pm at 37 Rue Auguste Piccard, 6041 Gosselies, Belgium.

    The notice for the meeting, including the agenda of the day as well as the motions too vote, have been published in the Belgian Official Gazette and L’Echo on 28 April 2015.

    The documents and preliminary information concerning this meeting are being made available to the shareholders and can be consulted on the website of the Company: www.bonetherapeutics.com, under the section Investors / Shareholders meeting, in compliance with the applicable law and regulations.

    It is

    Read More »from Bone Therapeutics: The Preparatory Documents for the Annual General Shareholder Meeting on 28 May 2015 Have Been Made Available
    Contact:
    Bone Therapeutics SA
    Enrico Bastianelli, Chief Executive Officer / Wim Goemaere, Chief Financial Officer
    Tel: +32 (0)2 529 59 90
    investorrelations@bonetherapeutics.com
    or
    For Belgium and International Media Enquiries
    Consilium Strategic Communications
    Amber Bielecka, Mary-Jane Elliott, Jessica Hodgson and Lindsey Neville
    Tel: +44 (0) 20 3709 5701
    bonetherapeutics@consilium-comms.com
    or
    For French Media and Investor Enquiries
    NewCap Investor Relations & Financial Communications
    Pierre Laurent and Antoine Denry
    Tel: + 33 (0)1 44 71 94 94
    bone@newcap.fr
  • CAMBRIDGE, Mass.--(BUSINESS WIRE)--

    Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has granted Fast Track designation for the development of GZ/SAR402671, a new investigational oral substrate reduction therapy for the treatment of Fabry disease.

    FDA’s Fast Track Drug Development Program is designed to facilitate frequent interactions with the FDA review team to expedite the clinical development and review of a New Drug Application (NDA) for medicines with the potential to treat serious or life-threatening conditions and address unmet medical needs for such disease or conditions. It also provides the opportunity to submit sections of an NDA on a rolling basis before a sponsor submits the complete application. Genzyme is currently enrolling patients in its Phase 2a trial of GZ/SAR402671, and plans to enroll nine treatment-naïve male adult

    Read More »from FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease
    Contact:
    Genzyme Media Relations
    Lori Gorski +1 617-768-9344
    lori.gorski@genzyme.com
    or
    Sanofi Investor Relations
    Sébastien Martel, +33 (0) 1 53 77 45 43
    ir@sanofi.com
  • LONDON--(BUSINESS WIRE)--

    DigitalGlobe, Inc. (DGI), a leading global provider of high-resolution earth imagery and geospatial solutions, today announced the general availability of its Basemap +Vivid product for the entire African continent. Keeping pace with the rapid evolution of mapping technology, this is the first time that a complete, consistent satellite imagery base layer with 50 cm ground resolution has been available for Africa.

    Many parts of Africa have never been mapped at this resolution from space, and never before has there been a complete imagery base map of Africa with this level of detail. While 50 cm satellite imagery for Africa has been available since 2008, it previously only covered smaller areas of interest. To meet the rapidly growing needs of our customers, DigitalGlobe purposed our satellite constellation to cover every country in Africa so we

    Read More »from DigitalGlobe Produces the World’s First Complete and Consistent High Resolution Satellite Imagery Base Map of Africa
    Contact:
    DigitalGlobe
    Nancy Coleman, 303-684-1674
    Senior Director of Communications
    nancy.coleman@digitalglobe.com
    or
    Investor Relations Contact:
    David Banks, 303-684-4210
    Vice President of Investor Relations
    ir@digitalglobe.com
    or
    Edelman for DigitalGlobe
    digitalglobe@edelman.com

Pagination

(13,39,858 Stories)

Follow Yahoo Finance India

QUOTES

 
Recent Quotes
Symbol Price Change % Chg 
Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
You need to enable your browser cookies to view your most recent quotes.
 
Sign-in to view quotes in your portfolios.